Heron Therapeutics (HRTX)
(Real Time Quote from BATS)
$1.78 USD
+0.03 (1.71%)
Updated Aug 5, 2025 11:42 AM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Heron Therapeutics, Inc. has a market cap of $266.99M, which represents its share price of $1.75 multiplied by its outstanding shares number of 152.56M. As a small-cap company, HRTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HRTX 1.78 +0.03(1.71%)
Will HRTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HRTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HRTX
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
HRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics
Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates
MTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise
Other News for HRTX
Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025 | ...
Heron Therapeutics: Middling Performance From Approved Therapies With No Pipeline
JW Asset Management, LLC Adjusts Position in Establishment Labs Holdings Inc
Heron Therapeutics Holds Annual Stockholders Meeting
Edison, Apple, Oklo, Heron, Fifth Third: Trending by Analysts